Publication in “Blood” : “BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML […]”

“BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells.”

Beurlet S, Omidvar N, Gorombei P, Krief P, Le Pogam C, Setterblad N, de la Grange P, Leboeuf C, Janin A, Noguera ME, Hervatin F, Sarda-Mantel L, Konopleva M, Andreeff M, Tu AW, Fan AC, Felsher DW, Whetton A, Pla M, West R, Fenaux P, Chomienne C, Padua RA., Blood, 2013 Aug.

Pubmed

This entry was posted in Article. Bookmark the permalink.

Comments are closed.